News

30th September 2025

Merakris Therapeutics Secures FDA Agreement for Type C Meeting to Advance MTX-001 Development Pathway

15th July 2025

Merakris Therapeutics Selected as Finalist for 2025 Advanced Wound Care Summit Innovation Showcase

10th April 2025

Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer

26th March 2025

International Wound Journal Publishes Positive Phase 2 Interim Data on Cell-free Amniotic Fluid Injectable Biologic for the Treatment of Venous Leg Ulcers

4th March 2025

2025 CAMPS Summit Selects Merakris Therapeutics’ Scientist with Inaugural “Best Comparative Trial” Award

1 2

Top